Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cornea ; 42(10): 1211-1215, 2023 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-36730367

RESUMEN

PURPOSE: The purpose of this study was to examine the effect of head trauma-related deaths on corneal endothelial cell density (ECD) in eye bank donors. METHODS: This is a retrospective study of 287 corneas from donors with causes of death secondary to motor vehicle accident with sustained head trauma (n = 50), gunshot wound to the head (n = 138), fall with sustained head trauma (n = 2), and non-head-related traumatic causes of death (n = 97). Donors older than age 50 years were excluded due to concern for undiagnosed Fuchs endothelial dystrophy as a potential confounder for the cause of endothelial cell loss. Donor characteristics, ECD, and focal endothelial cell loss on specular microscopy were compared between the groups. Donors in the head trauma and nonhead trauma groups were matched by age; there were 42 age-matched donors in both groups. RESULTS: Age and ECD were negatively correlated (Pearson correlation coefficient = -0.57). Death-to-preservation time was not significantly different between the 2 groups ( P value = 0.59). The mean ECD in the head trauma group was 2859 ± 370 cells/mm 2 and 3041 ± 464 cells/mm 2 in the nonhead trauma group. The head trauma group had a lower ECD (178 ± 70 cells/mm 2 , P value = 0.013). After matching for age, the difference in ECD between the 2 groups was -94 ± 82 cells/mm 2 ( P value = 0.26). The adjusted odds of having focal endothelial cell loss was not statistically significant ( P value = 0.50) between the groups. CONCLUSIONS: After statistical adjustments, there were no differences between the head trauma and nonhead trauma groups.


Asunto(s)
Traumatismos Craneocerebrales , Heridas por Arma de Fuego , Humanos , Persona de Mediana Edad , Pérdida de Celulas Endoteliales de la Córnea/diagnóstico , Endotelio Corneal , Bancos de Ojos , Estudios Retrospectivos , Heridas por Arma de Fuego/complicaciones , Donantes de Tejidos , Recuento de Células , Traumatismos Craneocerebrales/complicaciones
2.
J Acad Ophthalmol (2017) ; 15(1): e112-e118, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38737163

RESUMEN

Purpose The aim of this study was to evaluate regional disparities in access to EyeSi surgical simulation training among U.S. ophthalmology residency programs. Methods Access to EyeSi simulation was determined from sales data (2021) provided by VRMagic. Key demographic metrics of the primary counties of U.S. residency training programs were retrieved from the U.S. Census Bureau Database (2019) and PolicyMap (2021). Demographic metrics, Veterans Affairs (VA) hospital affiliation, and Doximity residency program ranking (2021) were compared using the Mann-Whitney U test and Fisher's exact test. Results A total of 124 residency training programs across 95 U.S. counties were included. Regional density (number of EyeSi simulators/million people) was calculated; the west had a significantly lower density when compared with the northeast (NE), south, and midwest (0.4 vs 1.0, 1.3, 1.1, respectively). In the NE, there was a significantly lower population of Blacks ( p = 0.01), Hispanics ( p = 0.028), and Native Americans ( p = 0.008) residing in counties with access to EyeSi, compared with counties without EyeSi access. Programs with EyeSi access ( N = 95) had a median Doximity ranking of 52.5, whereas programs without EyeSi access ( N = 35) had a lower median ranking of 94 ( p < 0.001). Conclusion Our analysis demonstrates significant disparities in access to EyeSi simulation training in the United States that could disproportionately impact minority communities. Access to an EyeSi simulator was associated with higher residency ranking independent of VA affiliation.

3.
J Ophthalmol ; 2022: 8011745, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36091576

RESUMEN

Purpose: To determine the efficacy and safety of phacoemulsification, clear lensectomy, and the Hydrus microstent (Ivantis, Inc.) in Black and Afro-Latino glaucoma patients. Method: This is a retrospective nonrandomized study of 134 Black and Afro-Latino patients who underwent clear lensectomy with Hydrus stent implant for the treatment of glaucoma. For comprehensive analysis, patients were divided into mild, moderate, and advanced glaucoma. The evaluated parameters were reductions in the number of medications, intraocular pressure (IOP), mean deviation on visual field test, and visual acuity. Results: A total of 134 patients with 1-year follow-up were evaluated. At 1 year, the average number of medications significantly decreased from 2.5 ± 1.4 preoperatively to 0.43 ± 1.04 (p < 0.001) and IOP decreased from 14.4 ± 3.9 to 13.8 ± 3.10 (p=0.16). 110 (82.1%) patients were medication-free at 1 year (n = 57, 83.8% mild glaucoma; n = 37, 92.5% moderate glaucoma; n = 16, 61.5% advanced glaucoma). There was stabilization of mean deviation on the visual field test (baseline, -8.28; 1 year, -8.28; p=1). The most reported adverse effects were transient IOP spike and hyphema (n = 7, 5.2%; n = 3, 2.2%, respectively); both events were self-resolving. No decline in vision or sight-threatening complications were reported at 1 year, and no additional surgeries were required. Conclusion: This 1-year retrospective study demonstrated the efficacy and safety of clear lensectomy and Hydrus stent implantation in decreasing medication burden while maintaining lower IOP in Black and Afro-Latino glaucoma patients.

4.
J Natl Med Assoc ; 114(6): 584-588, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36167750

RESUMEN

PURPOSE: To report a case of a patient with juvenile-onset open-angle glaucoma (JOAG) who was successfully treated with combination cataract extraction and Hydrus stent implantation. METHODS: An interventional case report. RESULTS: The patient underwent cataract surgery and Hydrus stent implantation in the right eye. Preoperative intraocular pressure (IOP) was 25 mmHg in the right eye (OD) and 21 mmHg in the left eye (OS). Best-corrected visual acuities (BCVA) were 20/80 in the right eye and 20/200 in the left eye. Postoperatively, vision improved to 20/40 in the right eye with an IOP of 14 mmHg after 21 months follow up. No device-related complications were observed. CONCLUSIONS: Cataract surgery in combination with the Hydrus stent implant effectively lowers intraocular pressures and can be used to surgically manage patients with JOAG. This intervention is a probable adjunct or substitute to first line treatments such as trabeculotomy.


Asunto(s)
Extracción de Catarata , Catarata , Glaucoma de Ángulo Abierto , Glaucoma , Humanos , Glaucoma de Ángulo Abierto/complicaciones , Glaucoma de Ángulo Abierto/cirugía , Agudeza Visual , Tonometría Ocular , Glaucoma/cirugía , Catarata/complicaciones , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA